ArticleSe pu = Chinese journal of chromatography2025
[Internal exposure characteristics and health risk assessment of organophosphate esters in urban residents].
Article in Se pu = Chinese journal of chromatography, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Residue of Organophosphate Esters (OPEs) in the Crustacean from Southeast China and Its Dietary Exposure Risk Assessment.Journal of xenobiotics · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The contents of 15 organophosphate ester （OPE） metabolites in the urine of 1 869 adults residing in urban areas were quantified using ultra performance liquid chromatography-tandem mass spectrometry （UPLC-MS/MS）. How gender， age， body mass index （BMI）， smoking status， exercise frequency， family income and dietary intake affected the contents of OPE metabolites in human urine were discussed. Furthermore， the daily intake （EDI） of OPEs was evaluated based on the contents of OPE metabolites in urine. The corresponding potential non-carcinogenic risks were calculated in combination with the non-carcinogenic risk reference dose （RfD）， with the health risks of individual OPE monomers and overall cumulative exposure expressed using the hazard quotient （HQ） and hazard index （HI）. Six OPE metabolites exhibited detection frequencies in excess of 60%， with bis（2-butoxyethyl） phosphate （BBOEP） and 1-hydroxy-2-propyl bis（1-chloro-2-propyl） phosphate （BCIPHIPP）， as the two main OPE metabolites， detected at levels of 0.56 and 0.36 ng/mL， respectively. Men exhibited higher urine contents of bis（1，3-dichloro-2-propyl） phosphate （BDCIPP）， BCIPHIPP， and BBOEP than women， whereas women exhibited higher urine contents of 4-hydroxyphenyl-phenylphosphate （4-HO-DPHP）. The levels of BCIPHIPP and diphenyl phosphate （DPHP） were found to correlate negatively with age， while the BCIPHIPP， and di-
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.